Terms ending in 2031
Every in-force patent on Bayer AG's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,168,324 | Production of Polyurethane Foams for Wound Management In force · High confidence | Covestro Deutschland AG | In force | High confidence | |
| US 8,479,413 | Footwear Insole for Alleviating Arthritis Pain In force · High confidence | Scholl's Wellness Company LLC | In force | High confidence | |
| US 8,869,371 | Method for Producing Radiation Modules In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| US 8,956,308 | Integrated-Testing System In force · High confidence | Ascensia Diabetes Care Holdings AG | In force | High confidence | |
| US 8,748,622 | Process for the Preparation of 4-{4-[({[4-Chloro-3-(TRIFLUOROMETHYL)-PHENYL]AMINO}CARBONYL)AMINO]-3-Fluorophenoxy}-N-METHYLPYRIDINE-2-Carboxamide, Its Salts and Monohydrate In force · High confidence | Bayer Healthcare LLC | In force | High confidence | |
| US 9,458,107 | Process for the Preparation of 4-{4-[({[4-Chloro-3-(TRIFLUOROMETHYL)-PHENYL]AMINO}CARBONYL)AMINO]-3-Fluorophenoxy}-N-ETHYLPYRIDINE-2-Carboxamide, Its Salts and Monohydrate In force · Medium confidence | Bayer Healthcare LLC | In force | Medium confidence | |
| US 8,492,544 | Process for Preparing Methyl {4,6-Diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and Its Purification for Use as Pharmaceutically Active Compound In force · High confidence | Adverio Pharma GmbH | In force | High confidence | |
| US 8,501,945 | Process for Preparing Methyl {4,6-Diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and Its Purification for Use as Pharmaceutically Active Compound In force · High confidence | Adverio Pharma GmbH | In force | High confidence | |
| US 8,420,656 | Substituted 5-Fluoro-1H-PYRAZOLOPYRIDINES and Their Use In force · High confidence | Adverio Pharma GmbH | In force | High confidence | |
| US 8,921,377 | Substituted 5-fluoro-1H-pyrazolopyridines and their use In force · Medium confidence | Adverio Pharma GmbH | In force | Medium confidence | |
| 14 more term ends in 2031 · Pro | |||||
10 of 24 patents shown. Soonest term end first, then patent number.
Pro members see all 24.
4 of these are in force and held by Bayer AG.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.